Changes in predicted cardiovascular disease risk after biliopancreatic diversion surgery in severely obese patients

Metabolism: Clinical and Experimental

Volumn 63, Issue 1, 2014, Pages 79-86

  Piché, Marie Ève ^a   Martin, Julie ^a   Cianflone, Katherine ^a   Bastien, Marjorie ^a   Marceau, Simon ^a   Biron, Simon ^a   Hould, Frédéric Simon ^a   Poirier, Paul ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Bariatric surgery; Cardiovascular risk; Metabolic profile; Severely obese

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRY; ARTICLE; BILIOPANCREATIC BYPASS; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; FRAMINGHAM RISK SCORE; HEMOGLOBIN BLOOD LEVEL; HUMAN; ISCHEMIC HEART DISEASE; LIFESPAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

ADULT TREATMENT PANEL III; ATP III; BARIATRIC SURGERY; BILIOPANCREATIC DIVERSION WITH DUODENAL SWITCH; BMI; BODY MASS INDEX; BPD-DS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHD; CORONARY HEART DISEASE; CVD; HIGH SENSITIVE C-REACTIVE PROTEIN; HOMA INSULIN RESISTANCE MODEL; HOMA-IR; HS-CRP; METABOLIC PROFILE; NATIONAL INSTITUTE OF HEALTH; NIH; SEVERELY OBESE; SOS; SWEDISH OBESE SUBJECTS GROUP;

ADULT; ANTIHYPERTENSIVE AGENTS; APOLIPOPROTEINS; BILIOPANCREATIC DIVERSION; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; OBESITY, MORBID; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TRIGLYCERIDES; WEIGHT LOSS;

EID: 84890118108     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2013.09.004     Document Type: Article

References (34)

1. P. Poirier, M.A. Cornier, and T. Mazzone Bariatric surgery and cardiovascular risk factors: a scientific statement from the American Heart Association Circulation 123 15 2011 1683 1701
2. M.A. Cornier, J.P. Despres, and N. Davis Assessing adiposity: a scientific statement from the American Heart Association Circulation 124 18 2011 1996 2019
3. C.E. Lewis, K.M. McTigue, and L.E. Burke Mortality, health outcomes, and body mass index in the overweight range: a science advisory from the American Heart Association Circulation 119 25 2009 3263 3271
4. P. Mathieu, P. Poirier, P. Pibarot, I. Lemieux, and J.P. Despres Visceral obesity: the link among inflammation, hypertension, and cardiovascular disease Hypertension 53 4 2009 577 584
5. P. Poirier, M.A. Alpert, and L.A. Fleisher Cardiovascular evaluation and management of severely obese patients undergoing surgery: a science advisory from the American Heart Association Circulation 120 1 2009 86 95
6. J.L. Colquitt, J. Picot, E. Loveman, and A.J. Clegg Surgery for obesity Cochrane Database Syst Rev 2 2009 CD003641
7. I. Nault, E. Nadreau, and C. Paquet Impact of bariatric surgery-induced weight loss on heart rate variability Metabolism 56 10 2007 1425 1430
8. H. Buchwald, Y. Avidor, and E. Braunwald Bariatric surgery: a systematic review and meta-analysis JAMA 292 14 2004 1724 1737
9. L. Sjostrom, M. Peltonen, and P. Jacobson Bariatric surgery and long-term cardiovascular events JAMA 307 1 2012 56 65
10. D.W. Nelson, K.S. Blair, and M.J. Martin Analysis of obesity-related outcomes and bariatric failure rates with the duodenal switch vs gastric bypass for morbid obesity Arch Surg 147 9 2012 847 854
11. S. Mottillo, K.B. Filion, and J. Genest The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis J Am Coll Cardiol 56 14 2010 1113 1132
12. L.A. Leiter, D.H. Fitchett, and R.E. Gilbert Cardiometabolic risk in Canada: a detailed analysis and position paper by the cardiometabolic risk working group Can J Cardiol 27 2 2011 e1 e33
13. P.W. Wilson, R.B. D'Agostino, D. Levy, A.M. Belanger, H. Silbershatz, and W.B. Kannel Prediction of coronary heart disease using risk factor categories Circulation 97 18 1998 1837 1847
14. D.M. Lloyd-Jones, E.P. Leip, and M.G. Larson Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age Circulation 113 6 2006 791 798
15. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 7 1985 412 419
16. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation 106 25 2002 3143 3421
17. A.K. Marma, J.D. Berry, H. Ning, S.D. Persell, and D.M. Lloyd-Jones Distribution of 10-year and lifetime predicted risks for cardiovascular disease in US adults: findings from the National Health and Nutrition Examination Survey 2003 to 2006 Circ Cardiovasc Qual Outcomes 3 1 2010 8 14
18. G.W. Strain, J. Wang, M. Gagner, A. Pomp, W.B. Inabnet, and S.B. Heymsfield Bioimpedance for severe obesity: comparing research methods for total body water and resting energy expenditure Obesity (Silver Spring) 16 8 2008 1953 1956
19. A.A. Leal, J. Faintuch, and A.A. Morais Bioimpedance analysis: should it be used in morbid obesity? Am J Hum Biol 23 3 2011 420 422
20. J. Martin, S. Bergeron, and P. Pibarot Impact of bariatric surgery on N-terminal fragment of the prohormone brain natriuretic peptide and left ventricular diastolic function Can J Cardiol 29 8 2013 969 975
21. W.T. Friedewald, R.I. Levy, and D.S. Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin Chem 18 6 1972 499 502
22. C. Compher, and K.O. Badellino Obesity and inflammation: lessons from bariatric surgery JPEN J Parenter Enteral Nutr 32 6 2008 645 647
23. H. Nakatani, K. Kasama, T. Oshiro, M. Watanabe, H. Hirose, and H. Itoh Serum bile acid along with plasma incretins and serum high-molecular weight adiponectin levels are increased after bariatric surgery Metabolism 58 10 2009 1400 1407
24. R. Chakaroun, M. Raschpichler, and N. Kloting Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity Metabolism 61 5 2012 706 714
25. J.A. Vogel, B.A. Franklin, and K.C. Zalesin Reduction in predicted coronary heart disease risk after substantial weight reduction after bariatric surgery Am J Cardiol 99 2 2007 222 226
26. V. Catalan, J. Gomez-Ambrosi, and B. Ramirez Proinflammatory cytokines in obesity: impact of type 2 diabetes mellitus and gastric bypass Obes Surg 17 11 2007 1464 1474
27. A.E. Pontiroli, F. Folli, and M. Paganelli Laparoscopic gastric banding prevents type 2 diabetes and arterial hypertension and induces their remission in morbid obesity: a 4-year case-controlled study Diabetes Care 28 11 2005 2703 2709
28. A.E. Pontiroli, P. Pizzocri, and M.C. Librenti Laparoscopic adjustable gastric banding for the treatment of morbid (grade 3) obesity and its metabolic complications: a three-year study J Clin Endocrinol Metab 87 8 2002 3555 3561
29. H. Buchwald, R. Estok, and K. Fahrbach Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis Am J Med 122 3 2009 248 256
30. L.A. Vazquez, F. Pazos, and J.R. Berrazueta Effects of changes in body weight and insulin resistance on inflammation and endothelial function in morbid obesity after bariatric surgery J Clin Endocrinol Metab 90 1 2005 316 322
31. H.P. Kopp, K. Krzyzanowska, M. Mohlig, J. Spranger, A.F. Pfeiffer, and G. Schernthaner Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women Int J Obes (Lond) 29 7 2005 766 771
32. J. Gomez-Ambrosi, A. Rodriguez, V. Catalan, and G. Fruhbeck The bone-adipose axis in obesity and weight loss Obes Surg 18 9 2008 1134 1143
33. R.H. Mackey, S.H. Belle, and A.P. Courcoulas Distribution of 10-year and lifetime predicted risk for cardiovascular disease prior to surgery in the longitudinal assessment of bariatric surgery-2 study Am J Cardiol 110 8 2012 1130 1137
34. P. Marceau, S. Biron, and F.S. Hould Duodenal switch: long-term results Obes Surg 17 11 2007 1421 1430